Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the contributions of cuproptosis in the development of hypertrophic scar using single-cell analysis and machine learning techniques. | Front Immunol | 2023 | 37409114 | PubTator, text mining | PubMed |
| Comparative analysis of machine learning approaches for predicting respiratory virus infection and symptom severity. | PeerJ | 2023 | 37404475 | PubTator, text mining | PubMed |
| A Glimpse into the Genome-wide DNA Methylation Changes in 6-hydroxydopamine-induced In Vitro Model of Parkinson's Disease. | Exp Neurobiol | 2023 | 37403221 | PubTator, text mining | PubMed |
| Structural Organization of the Retriever-CCC Endosomal Recycling Complex. | Res Sq | 2023 | 37397996 | PubTator, text mining | PubMed |
| Cervical cancer: a tale from HPV infection to PARP inhibitors. | Genes Dis | 2023 | 37397551 | PubTator, text mining | PubMed |
| Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer. | Genes Dis | 2023 | 37397523 | PubTator, text mining | PubMed |
| Regulation of Atp7a RNA contributes to differentiation-dependent Cu redistribution in skeletal muscle cells. | Metallomics | 2023 | 37391383 | PubTator, text mining | PubMed |
| Impact of Cuproptosis-related markers on clinical status, tumor immune microenvironment and immunotherapy in colorectal cancer: A multi-omic analysis. | Comput Struct Biotechnol J | 2023 | 37389187 | PubTator, text mining | PubMed |
| The biological significance of cuproptosis-key gene MTF1 in pan-cancer and its inhibitory effects on ROS-mediated cell death of liver hepatocellular carcinoma. | Discov Oncol | 2023 | 37380924 | PubTator, text mining | PubMed |
| The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. | Cells | 2023 | 37371141 | PubTator, text mining | PubMed |
| Preparation of Ultra-Small Copper Nanoparticles-Loaded Self-Healing Hydrogels with Antibacterial, Inflammation-Suppressing and Angiogenesis-Enhancing Properties for Promoting Diabetic Wound Healing. | Int J Nanomedicine | 2023 | 37361387 | PubTator, text mining | PubMed |
| Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance. | Front Pharmacol | 2023 | 37361215 | PubTator, text mining | PubMed |
| Medicinal chemistry approaches to target the MNK-eIF4E axis in cancer. | RSC Med Chem | 2023 | 37360400 | PubTator, text mining | PubMed |
| ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 | 37347242 | PubTator, text mining | PubMed |
| Editorial: Genes, diseases, immunity and immunogenomics. | Front Genet | 2023 | 37347057 | PubTator, text mining | PubMed |
| Spatial pattern and influential factors for early marriage: evidence from Bangladesh Demographic Health Survey 2017-18 data. | BMC Womens Health | 2023 | 37340425 | PubTator, text mining | PubMed |
| Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma. | BMC Cancer | 2023 | 37330494 | PubTator, text mining | PubMed |
| The Contributions of Trace Elements on Molecular Subtype-Specific Colorectal Cancer. | J Cancer | 2023 | 37325050 | PubTator, text mining | PubMed |
| Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis. | Int J Med Sci | 2023 | 37324184 | PubTator, text mining | PubMed |
| Cuproptosis-related gene identification and immune infiltration analysis in systemic lupus erythematosus. | Front Immunol | 2023 | 37313407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=20